Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.

Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S.

BJU Int. 2012 Jun;109(11):1716-26. doi: 10.1111/j.1464-410X.2011.10706.x. Epub 2012 Jan 5.

2.

When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.

DeGraff DJ, Cates JM, Mauney JR, Clark PE, Matusik RJ, Adam RM.

Urol Oncol. 2013 Aug;31(6):802-11. doi: 10.1016/j.urolonc.2011.07.017. Epub 2011 Sep 15. Review.

3.

Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity.

Gakis G, Stenzl A.

World J Urol. 2013 Oct;31(5):1059-64. doi: 10.1007/s00345-013-1037-z. Epub 2013 Feb 9. Review.

PMID:
23397433
4.

Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma.

Miyamoto H, Zheng Y, Izumi K.

Curr Cancer Drug Targets. 2012 Jan;12(1):14-22. Review.

PMID:
22111835
5.

Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.

Fransen van de Putte EE, Behrendt MA, Pigot GL, van der Kwast TH, van Rhijn BW.

Curr Opin Urol. 2015 Sep;25(5):427-35. doi: 10.1097/MOU.0000000000000202. Review.

PMID:
26125511
6.

Role of oestrogen receptors in bladder cancer development.

Hsu I, Vitkus S, Da J, Yeh S.

Nat Rev Urol. 2013 Jun;10(6):317-26. doi: 10.1038/nrurol.2013.53. Epub 2013 Apr 16. Review.

PMID:
23588401
7.

The role of the androgen receptor in the development and progression of bladder cancer.

Li Y, Izumi K, Miyamoto H.

Jpn J Clin Oncol. 2012 Jul;42(7):569-77. doi: 10.1093/jjco/hys072. Epub 2012 May 15. Review.

8.

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Hodi Z, Chakrabarti J, Lee AH, Ronan JE, Elston CW, Cheung KL, Robertson JF, Ellis IO.

J Clin Pathol. 2007 Mar;60(3):299-302. Epub 2006 May 26. Review.

9.

Novel agents in invasive urothelial cancer.

Balar AV, Milowsky MI.

Clin Adv Hematol Oncol. 2012 Aug;10(8):504-16. Review.

PMID:
23073049
10.

[Tumour-stroma interactions in urothelial cancer].

Hatina J, Kripnerová M, Tuková J, Šrámek J, Dvořák P, Pešta M, Dobrá J, Babuška V, Racek J, Sobol M, Philimonenko A, Hozák P, Czuba Z, Schulz WA, Strell C, Grimm S, Jennek S, Friedrich KH.

Urologe A. 2015 Apr;54(4):516-25. doi: 10.1007/s00120-014-3754-3. Review. German.

PMID:
25895564
11.

Molecular pathogenesis and diagnostics of bladder cancer.

Mitra AP, Cote RJ.

Annu Rev Pathol. 2009;4:251-85. doi: 10.1146/annurev.pathol.4.110807.092230. Review.

PMID:
18840072
12.

The emerging role of the androgen receptor in bladder cancer.

Lombard AP, Mudryj M.

Endocr Relat Cancer. 2015 Oct;22(5):R265-77. doi: 10.1530/ERC-15-0209. Epub 2015 Jul 30. Review.

13.

Bladder cancer stem cells.

Tran MN, Goodwin Jinesh G, McConkey DJ, Kamat AM.

Curr Stem Cell Res Ther. 2010 Dec;5(4):387-95. Review.

PMID:
20955163
14.

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Knowles MA, Hurst CD.

Nat Rev Cancer. 2015 Jan;15(1):25-41. doi: 10.1038/nrc3817. Review.

PMID:
25533674
15.

Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity.

Mauvais-Jarvis F.

Trends Endocrinol Metab. 2011 Jan;22(1):24-33. doi: 10.1016/j.tem.2010.10.002. Epub 2010 Nov 5. Review.

16.

Potential therapeutic targets for the primary gallbladder carcinoma: estrogen receptors.

Zhang LQ, Zhang XD, Xu J, Wan Y, Qu K, Zhang JY, Wang ZX, Wei JC, Meng FD, Tai MH, Zhou L, Liu C.

Asian Pac J Cancer Prev. 2013;14(4):2185-90. Review.

17.

Microcystic variant of urothelial carcinoma.

Venyo AK.

Adv Urol. 2013;2013:654751. doi: 10.1155/2013/654751. Epub 2013 Dec 2. Review.

18.

Nested variant of urothelial carcinoma.

Venyo AK.

Adv Urol. 2014;2014:192720. doi: 10.1155/2014/192720. Epub 2014 Jan 22. Review.

19.

[Gender Aspects in Gastrointestinal Tumours and Their Prognosis in Regard to Multimodal Treatment Concepts].

Seeland U, Heger U, Heise K, Ott K.

Zentralbl Chir. 2015 Jun;140(3):266-72. doi: 10.1055/s-0035-1545963. Epub 2015 Jun 26. Review. German.

PMID:
26114635
20.

The interplay of extracellular matrix and microbiome in urothelial bladder cancer.

Alfano M, Canducci F, Nebuloni M, Clementi M, Montorsi F, Salonia A.

Nat Rev Urol. 2016 Feb;13(2):77-90. doi: 10.1038/nrurol.2015.292. Epub 2015 Dec 15. Review.

PMID:
26666363
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk